GlobeNewswire
-
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
23/12/2025 -
Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
23/12/2025 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
23/12/2025 -
J-Star’s LITZMO Introduces ER-01: The Brand’s First Carbon Fiber Fat-Tire E‑Assist Bicycle
23/12/2025 -
Merit Medical to Participate at the J.P. Morgan Healthcare Conference
23/12/2025 -
Best Sermorelin Tablet for 2026? bmiMD Platform Lists Mint Sublingual Format at $79/Month as Peptide Wellness Interest Surges Before New Year
23/12/2025 -
Best GLP-1 Gummies for 2026: Akkermansia Probiotic Supplements for Weight Loss – Industry Analysis
23/12/2025 -
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
22/12/2025 -
RxSight, Inc. Announces Chief Financial Officer Transition
22/12/2025 -
Apollomics Reports First Half 2025 Financial Results
22/12/2025 -
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
22/12/2025 -
TOMI Environmental Solutions Expands Footprint in Cell and Gene Therapy Sector with Multi-Stage SteraMist iHP Implementation at a New Pharmaceutical Manufacturing Site
22/12/2025 -
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
22/12/2025 -
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
22/12/2025 -
Celularity Announces Closing of Financing Transactions
22/12/2025 -
Alvotech’s Financial Calendar for 2026
22/12/2025 -
Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded.
22/12/2025 -
Vivos Inc Summarizes Progress in its Animal Therapy Division
22/12/2025 -
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
22/12/2025
Pages